Levin Capital Strategies, L.P. Pfizer Inc Transaction History

Levin Capital Strategies, L.P.

$952 Million
Q2 2024

A detailed history of Levin Capital Strategies, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 8,191 shares of PFE stock, worth $238,276. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,191

Previous 8,000 2.39%

Holding current value

$238,276

Previous $222,000 3.15%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $4,824 - $5,653	191 Added 2.39%	8,191 $229,000
Q1 2024 May 16, 2024	SELL	$25.89 - $29.73 $1.86 Million - $2.14 Million	-71,848 Reduced 89.98%	8,000 $222,000
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $2.36 Million - $3.06 Million	-90,183 Reduced 53.04%	79,848 $2.3 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $441,815 - $516,437	-13,768 Reduced 7.49%	170,031 $5.64 Million
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $3.68 Million - $4.26 Million	-101,859 Reduced 35.66%	183,799 $6.74 Million
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $98,238 - $127,892	2,494 Added 0.88%	285,658 $11.7 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $567,549 - $740,873	-13,594 Reduced 4.58%	283,164 $14.5 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $2.09 Million - $2.56 Million	-47,863 Reduced 13.89%	296,758 $13 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $654,444 - $775,966	-14,065 Reduced 3.92%	344,621 $18.1 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $743,620 - $921,439	-16,254 Reduced 4.34%	358,686 $18.6 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $442,537 - $655,987	-10,710 Reduced 2.78%	374,940 $22.1 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $140,475 - $180,453	3,579 Added 0.94%	385,650 $16.6 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $6.3 Million - $7.14 Million	175,459 Added 84.92%	382,071 $15 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $358,309 - $404,101	10,699 Added 5.46%	206,612 $7.49 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $290,218 - $369,037	-8,671 Reduced 4.24%	195,913 $7.21 Million
Q3 2020 Nov 17, 2020	BUY	$31.75 - $37.25 $434,340 - $509,580	13,680 Added 7.17%	204,584 $7.51 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $5.35 Million - $6.49 Million	-177,667 Reduced 48.2%	190,904 $6.24 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $8.02 Million - $11.5 Million	-296,688 Reduced 44.6%	368,571 $12 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $1.15 Million - $1.3 Million	-34,783 Reduced 4.97%	665,259 $26.1 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $9.9 Million - $12.8 Million	-304,850 Reduced 30.34%	700,042 $25.2 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $4.79 Million - $5.38 Million	129,510 Added 14.79%	1,004,892 $43.5 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $131 Million - $144 Million	-3,498,439 Reduced 79.99%	875,382 $37.2 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $77.5 Million - $88.4 Million	-2,015,632 Reduced 31.55%	4,373,821 $191 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $6.13 Million - $7.44 Million	-177,951 Reduced 2.71%	6,389,453 $282 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $17.3 Million - $18.4 Million	-523,645 Reduced 7.38%	6,567,404 $238 Million
Q1 2018 May 18, 2018	SELL	$31.91 - $37.02 $71.9 Million - $83.4 Million	-2,252,636 Reduced 24.11%	7,091,049 $252 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $31.7 Million - $33.6 Million	-952,492 Reduced 9.25%	9,343,685 $338 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $319 Million - $352 Million	10,296,177	10,296,177 $368 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account

Levin Capital Strategies, L.P. Pfizer Inc Transaction History